# GFA Production Xiamen Co., Ltd., Xiamen, China – FDA Inspections

Source: https://www.keypedia.com/companies/gfa-production-xiamen-co-ltd/569f8078-cfa9-46d0-bd48-40282293e2a3

> Inspection records and compliance data for GFA Production Xiamen Co., Ltd. in Xiamen. 6 FDA inspections on record (1 OAI), 1 Form 483, 1 warning letter, last inspected December 08, 2023.

---

## Details

- Name: GFA Production Xiamen Co., Ltd.
- FEI Number: 3008384335
- Address Line 1: Huli Industrial Park No. 20, Meixi Street; Tongan
- City: Xiamen
- Country Name: China
- Address: Huli Industrial Park No. 20, Meixi Street; Tongan, Xiamen, China
- Country: China

## Related Documents

- [483 - GFA Production Xiamen Co., Ltd. - 2023-12-08](https://www.keypedia.com/records/483/gfa-production-xiamen-co-ltd/e69ac240-a296-4168-867b-caa0a40f7e0b) — source: FDA, date: December 8, 2023
- [WARNING_LETTER - GFA Production Xiamen Co., Ltd. - 2023-12-08](https://www.keypedia.com/records/warning_letter/gfa-production-xiamen-co-ltd/6d754766-2d37-445a-a500-a7d001947e95) — source: FDA, date: December 8, 2023
- [FDA Inspection 1227212 - GFA Production Xiamen Co., Ltd. - 2023-12-08](https://www.keypedia.com/records/fda_inspections/gfa-production-xiamen-co-ltd/7fa099f3-e058-49da-ac9f-69100239201f) — classification: Official Action Indicated (OAI), source: FDA, date: December 8, 2023
- FDA Inspection 1090670 - GFA Production Xiamen Co., Ltd. - 2019-04-12 — classification: No Action Indicated (NAI), source: FDA, date: April 12, 2019
- FDA Inspection 998185 - GFA Production Xiamen Co., Ltd. - 2016-12-15 — classification: No Action Indicated (NAI), source: FDA, date: December 15, 2016
- FDA Inspection 999364 - GFA Production Xiamen Co., Ltd. - 2016-12-08 — source: FDA, date: December 8, 2016
- FDA Inspection 909122 - GFA Production Xiamen Co., Ltd. - 2014-11-07 — classification: No Action Indicated (NAI), source: FDA, date: November 7, 2014
- FDA Inspection 851259 - GFA Production Xiamen Co., Ltd. - 2013-09-26 — classification: No Action Indicated (NAI), source: FDA, date: September 26, 2013
- [FDA Inspection 851259 - GFA Production Xiamen Co., Ltd. - 2013-09-26](https://www.keypedia.com/records/fda_inspections/gfa-production-xiamen-co-ltd/3afb6692-7ebe-41bd-b61f-291dee30c8d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 26, 2013

## Related Companies

- [Children's National Medical Center IRB](https://www.keypedia.com/companies/childrens-national-medical-center-irb/b85c818b-4db6-4f98-a73b-5ba95b927999)
- [University of North Texas Health Science Center-IRB](https://www.keypedia.com/companies/university-of-north-texas-health-science-center-irb/f587e370-1903-4150-b994-4f11bd54dd27)
- [Medisca Inc](https://www.keypedia.com/companies/medisca-inc/7448a6fa-f3ce-459e-aaed-4449c225f9c4)
- [Ortec](https://www.keypedia.com/companies/ortec/e7a88df3-0ce8-4995-83ef-628dbc45bd8f)
- [Spaulding Medical LLC](https://www.keypedia.com/companies/spaulding-medical-llc/7ac7fe7b-ab8d-41fd-91d5-7c25204c736d)
- [Mylan Pharmaceuticals Inc.](https://www.keypedia.com/companies/mylan-pharmaceuticals-inc/544e75ba-feb1-4947-b3da-4883556581f1)
- [Jeffrey S. Dover, MD](https://www.keypedia.com/companies/jeffrey-s-dover-md/1917bf80-d3a9-4f10-90f3-cbc98b21d811)
- [Ascension Sacred Heart Hospital IRB](https://www.keypedia.com/companies/ascension-sacred-heart-hospital-irb/adb4800f-e377-49d6-a31d-eb80a3d4ccda)
- [Centracare St. Cloud Hospital - Irb](https://www.keypedia.com/companies/centracare-st-cloud-hospital-irb/8de7d0dc-d983-4c06-8616-483edd99f3f4)
- [All Pharma, LLC](https://www.keypedia.com/companies/all-pharma-llc/99218d35-8eb9-40af-b0f1-381af10ff3da)

## Related Officers

- [Hung H. Do](https://www.keypedia.com/people/hung-h-do/580f78ba-ed7a-4c10-8f4c-a99d0af7206e)
- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
